{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T01:55:50Z","timestamp":1791856550068,"version":"4.3.4"},"reference-count":56,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T00:00:00Z","timestamp":1719360000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008272","name":"Novartis Pharmaceuticals Corp","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK125782"],"award-info":[{"award-number":["R01DK125782"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["TNE-18CVD04"],"award-info":[{"award-number":["TNE-18CVD04"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["R01HL148565"],"award-info":[{"award-number":["R01HL148565"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["R01HL142711"],"award-info":[{"award-number":["R01HL142711"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["R01HL135242"],"award-info":[{"award-number":["R01HL135242"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["R01HL151283"],"award-info":[{"award-number":["R01HL151283"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["R01HL151152"],"award-info":[{"award-number":["R01HL151152"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["5T32HL125232"],"award-info":[{"award-number":["5T32HL125232"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["R01HL148050"],"award-info":[{"award-number":["R01HL148050"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["R01HL159156"],"award-info":[{"award-number":["R01HL159156"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["R01HL127564"],"award-info":[{"award-number":["R01HL127564"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005294","name":"Massachusetts General Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005294","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001674","name":"Fondation Leducq","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001674","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jlr.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Lipid Research"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.jlr.2024.100585","type":"journal-article","created":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T11:36:39Z","timestamp":1719401799000},"page":"100585","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Associations between lipoprotein(a), oxidized phospholipids, and extracoronary vascular disease"],"prefix":"10.1016","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6884-3117","authenticated-orcid":false,"given":"Tiffany R.","family":"Bellomo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2876-8567","authenticated-orcid":false,"given":"Yuxi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas C.","family":"Gilliland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Miksenas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Haidermota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingdi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaquim Rosado","family":"Cristino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Auris","family":"Browne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Plutzky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sotirios","family":"Tsimikas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8338-1798","authenticated-orcid":false,"suffix":"Jr.","given":"James L.","family":"Januzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradeep","family":"Natarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jlr.2024.100585_bib1","doi-asserted-by":"crossref","first-page":"868370","DOI":"10.3389\/fcvm.2022.868370","article-title":"Burden of peripheral artery disease and its attributable risk factors in 204 countries and territories from 1990 to 2019","volume":"9","author":"Lin","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.jlr.2024.100585_bib2","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/S0140-6736(13)61576-7","article-title":"The global pandemic of peripheral artery disease","volume":"382","author":"Hirsch","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jlr.2024.100585_bib3","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1177\/1747493019832996","article-title":"Anthology of stroke epidemiology in the 20th and 21st centuries: assessing the past, the present, and envisioning the future","volume":"14","author":"Feigin","year":"2019","journal-title":"Int. J. Stroke"},{"key":"10.1016\/j.jlr.2024.100585_bib4","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s11357-022-00688-z","article-title":"Carotid disease, cognition, and aging: time to redefine asymptomatic disease?","volume":"45","author":"Lineback","year":"2023","journal-title":"Geroscience"},{"key":"10.1016\/j.jlr.2024.100585_bib5","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/j.jacc.2013.01.054","article-title":"Association between advanced age and vascular disease in different arterial territories: a population database of over 3.6 million subjects","volume":"61","author":"Savji","year":"2013","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.jlr.2024.100585_bib6","doi-asserted-by":"crossref","first-page":"E254","DOI":"10.1161\/CIR.0000000000000950","article-title":"Heart disease and stroke statistics - 2021 update: a report from the American heart association","volume":"143","author":"Virani","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jlr.2024.100585_bib7","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1161\/CIRCRESAHA.114.302721","article-title":"Mechanisms of plaque formation and rupture","volume":"114","author":"Bentzon","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.jlr.2024.100585_bib8","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1161\/ATVBAHA.119.312142","article-title":"Evidence-based medical management of peripheral artery disease","volume":"40","author":"Bevan","year":"2020","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.jlr.2024.100585_bib9","article-title":"Symptomatic upper extremity peripheral artery disease is associated with poor outcomes and a broad spectrum of etiologies","author":"Armengol","year":"2023","journal-title":"Angiology"},{"key":"10.1016\/j.jlr.2024.100585_bib10","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jash.2012.12.001","article-title":"Long-term follow-up of patients with atherosclerotic renal artery disease","volume":"7","author":"Safak","year":"2013","journal-title":"J.\u00a0Am. Soc. Hypertens."},{"key":"10.1016\/j.jlr.2024.100585_bib11","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ejvs.2013.03.024","article-title":"Short and long term mortality rates after a lower limb amputation","volume":"46","author":"Fortington","year":"2013","journal-title":"Eur. J. Vasc. Endovasc Surg."},{"key":"10.1016\/j.jlr.2024.100585_bib12","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1053\/j.ajkd.2021.06.025","article-title":"Atherosclerotic renovascular disease: a KDIGO (kidney disease: improving global outcomes) controversies conference","volume":"79","author":"Hicks","year":"2022","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.jlr.2024.100585_bib13","doi-asserted-by":"crossref","first-page":"2S","DOI":"10.1016\/j.jvs.2014.12.009","article-title":"Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: management of asymptomatic disease and claudication","volume":"61","author":"Conte","year":"2015","journal-title":"J.\u00a0Vasc. Surg."},{"key":"10.1016\/j.jlr.2024.100585_bib14","doi-asserted-by":"crossref","first-page":"4S","DOI":"10.1016\/j.jvs.2021.04.073","article-title":"Society for Vascular Surgery clinical practice guidelines for management of extracranial cerebrovascular disease","volume":"75","author":"AbuRahma","year":"2022","journal-title":"J.\u00a0Vasc. Surg."},{"key":"10.1016\/j.jlr.2024.100585_bib15","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1161\/01.CIR.91.9.2488","article-title":"Atherosclerosis: basic mechanisms","volume":"91","author":"Berliner","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.jlr.2024.100585_bib16","first-page":"166","article-title":"The role of lipids and lipoproteins in atherosclerosis","volume":"111","author":"Linton","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.jlr.2024.100585_bib17","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.120.006550","article-title":"Cause of death among patients with peripheral artery disease: insights from the EUCLID trial","volume":"13","author":"Kochar","year":"2020","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"key":"10.1016\/j.jlr.2024.100585_bib18","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1161\/CIRCULATIONAHA.120.046524","article-title":"Peripheral artery disease and venous thromboembolic events after acute coronary syndrome: role of lipoprotein(a) and modification by alirocumab: prespecified analysis of the Odyssey outcomes randomized clinical trial","volume":"141","author":"Schwartz","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jlr.2024.100585_bib19","first-page":"13","article-title":"Oxidized phospholipids and lipoprotein-associated phospholipase A2 as important determinants of Lp(a)functionality and pathophysiological role","volume":"32","author":"Tselepis","year":"2018","journal-title":"J.\u00a0Biomed. Res."},{"key":"10.1016\/j.jlr.2024.100585_bib20","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/339301a0","article-title":"A\u00a0potential basis for the thrombotic risks associated with lipoprotein(a)","volume":"339","author":"Miles","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.jlr.2024.100585_bib21","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1161\/01.RES.78.4.615","article-title":"Specific accumulation of lipoprotein(a) in balloon-injured rabbit aorta in\u00a0vivo","volume":"78","author":"Nielsen","year":"1996","journal-title":"Circ. Res."},{"key":"10.1016\/j.jlr.2024.100585_bib22","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1161\/01.ATV.15.9.1492","article-title":"Transfer of lipoprotein(a) and LDL into aortic intima in normal and in cholesterol-fed rabbits","volume":"15","author":"Nielsen","year":"1995","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.jlr.2024.100585_bib23","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/eurheartj\/ehl441","article-title":"Inflammatory, haemostatic, and rheological markers for incident peripheral arterial disease: Edinburgh Artery Study","volume":"28","author":"Tzoulaki","year":"2007","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.jlr.2024.100585_bib24","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/cvr\/cvu107","article-title":"Lipoprotein (a) concentrations, apolipoprotein (a) phenotypes, and peripheral arterial disease in three independent cohorts","volume":"103","author":"Laschkolnig","year":"2014","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.jlr.2024.100585_bib25","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.atherosclerosis.2018.07.001","article-title":"Lipoprotein (a) levels and outcomes in stable outpatients with symptomatic artery disease","volume":"276","author":"Sanchez Mu\u00f1oz-Torrero","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jlr.2024.100585_bib26","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1161\/ATVBAHA.112.255521","article-title":"Lipoprotein(a) and risk of coronary, cerebrovascular, and peripheral artery disease: the EPIC-Norfolk prospective population study","volume":"32","author":"Gurdasani","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.jlr.2024.100585_bib27","article-title":"Association of serum lipoprotein (a) with the requirement for a peripheral artery operation and the incidence of major adverse cardiovascular events in people with peripheral artery disease","volume":"9","author":"Golledge","year":"2020","journal-title":"J.\u00a0Am. Heart Assoc."},{"key":"10.1016\/j.jlr.2024.100585_bib28","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1016\/j.jacc.2016.10.033","article-title":"Phenotypic characterization of genetically lowered human lipoprotein(a) levels","volume":"68","author":"Emdin","year":"2016","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.jlr.2024.100585_bib29","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1161\/CIRCULATIONAHA.107.719369","article-title":"Symptomatic peripheral arterial disease in women: nontraditional biomarkers of elevated risk","volume":"117","author":"Pradhan","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jlr.2024.100585_bib30","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1001\/jama.285.19.2481","article-title":"Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease","volume":"285","author":"Ridker","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jlr.2024.100585_bib31","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1161\/CIRCULATIONAHA.116.023052","article-title":"Incident type 2 myocardial infarction in a cohort of patients undergoing coronary or peripheral arterial angiography","volume":"135","author":"Gaggin","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jlr.2024.100585_bib32","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1002\/clc.22939","article-title":"A\u00a0clinical and proteomics approach to predict the presence of obstructive peripheral arterial disease: from the Catheter Sampled Blood Archive in Cardiovascular Diseases (CASABLANCA) Study","volume":"41","author":"McCarthy","year":"2018","journal-title":"Clin. Cardiol."},{"key":"10.1016\/j.jlr.2024.100585_bib33","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1001\/jama.2012.13415","article-title":"Associations between conventional cardiovascular risk factors and risk of peripheral artery disease in men","volume":"308","author":"Joosten","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.jlr.2024.100585_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2022.100239","article-title":"Development and validation of an isoform-independent monoclonal antibody-based ELISA for measurement of lipoprotein(a)","volume":"63","author":"Marcovina","year":"2022","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.jlr.2024.100585_bib35","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1194\/jlr.R061648","article-title":"Lipoprotein (a) measurements for clinical application","volume":"57","author":"Marcovina","year":"2016","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.jlr.2024.100585_bib36","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1161\/01.CIR.0000130844.01174.55","article-title":"Percutaneous coronary intervention results in acute increases in oxidized phospholipids and lipoprotein(a): short-term and long-term immunologic responses to oxidized low-density lipoprotein","volume":"109","author":"Tsimikas","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jlr.2024.100585_bib37","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1016\/j.jacc.2013.02.047","article-title":"Oxidation-specific biomarkers and risk of peripheral artery disease","volume":"61","author":"Bertoia","year":"2013","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.jlr.2024.100585_bib38","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41569-023-00937-4","article-title":"Oxidized phospholipids in cardiovascular disease","volume":"21","author":"Tsimikas","year":"2024","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.jlr.2024.100585_bib39","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1016\/j.jacc.2023.02.050","article-title":"Lipoprotein(a), oxidized phospholipids, and coronary artery disease severity and outcomes","volume":"81","author":"Gilliland","year":"2023","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.jlr.2024.100585_bib40","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1016\/j.jacc.2018.11.002","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: executive summary: a report of the American College of Cardiology\/American heart association task force on clinical practice guidelines","volume":"73","author":"Grundy","year":"2019","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.jlr.2024.100585_bib41","article-title":"Lifetime risk of lower-extremity peripheral artery disease defined by ankle-brachial index in the United States","volume":"8","author":"Matsushita","year":"2019","journal-title":"J.\u00a0Am. Heart Assoc."},{"key":"10.1016\/j.jlr.2024.100585_bib42","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.45720","article-title":"Association of lipoprotein(a) levels with incidence of major adverse limb events","volume":"5","author":"Gu\u00e9don","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.jlr.2024.100585_bib43","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1001\/jamacardio.2022.0987","article-title":"Lipoprotein(a) and its significance in cardiovascular disease: a review","volume":"7","author":"Duarte","year":"2022","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.jlr.2024.100585_bib44","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.amjcard.2010.01.370","article-title":"Lipoprotein[a], inflammation, and peripheral arterial disease in a community-based sample of older men and women (the InCHIANTI study)","volume":"105","author":"Volpato","year":"2010","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.jlr.2024.100585_bib45","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1080\/07853890.2020.1775287","article-title":"Lipoprotein(a) in atherosclerosis: from pathophysiology to clinical relevance and treatment options","volume":"52","author":"Rehberger Likozar","year":"2020","journal-title":"Ann. Med."},{"key":"10.1016\/j.jlr.2024.100585_bib46","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1161\/01.STR.0000222666.21482.b6","article-title":"Lipoprotein(a) and incident ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) study","volume":"37","author":"Ohira","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.jlr.2024.100585_bib47","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1016\/j.jacc.2023.10.009","article-title":"Lipoprotein(a) and risks of peripheral artery disease, abdominal aortic aneurysm, and major adverse limb events","volume":"82","author":"Thomas","year":"2023","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.jlr.2024.100585_bib48","article-title":"Lipoprotein(a) and subclinical vascular and valvular calcification on cardiac computed tomography: the atherosclerosis risk in communities study","volume":"11","author":"Obisesan","year":"2022","journal-title":"J.\u00a0Am. Heart Assoc."},{"key":"10.1016\/j.jlr.2024.100585_bib49","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/s41569-018-0153-2","article-title":"Oxidized phospholipids as a unifying theory for lipoprotein(a) and cardiovascular disease","volume":"16","author":"Boffa","year":"2019","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.jlr.2024.100585_bib50","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1161\/CIRCULATIONAHA.116.020838","article-title":"Oxidized phospholipids on lipoprotein(a) elicit arterial wall inflammation and an inflammatory monocyte response in humans","volume":"134","author":"Van Der Valk","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jlr.2024.100585_bib51","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.jacc.2021.07.031","article-title":"PCSK9 inhibition and oxidized phospholipids","volume":"78","author":"Bhatia","year":"2021","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.jlr.2024.100585_bib52","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1161\/CIRCRESAHA.118.313864","article-title":"Potential causality and emerging medical therapies for lipoprotein(a) and its associated oxidized phospholipids in calcific aortic valve stenosis","volume":"124","author":"Tsimikas","year":"2019","journal-title":"Circ. Res."},{"key":"10.1016\/j.jlr.2024.100585_bib53","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jacc.2016.11.042","article-title":"A\u00a0test in context: lipoprotein(a): diagnosis, prognosis, controversies, and emerging therapies","volume":"69","author":"Tsimikas","year":"2017","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.jlr.2024.100585_bib54","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.jacc.2021.12.032","article-title":"Effect of pelacarsen on lipoprotein(a) cholesterol and corrected low-density lipoprotein cholesterol","volume":"79","author":"Yeang","year":"2022","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.jlr.2024.100585_bib55","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1161\/ATVBAHA.114.304785","article-title":"Race is a key variable in assigning lipoprotein(a) cutoff values for coronary heart disease risk assessment: the Multi-Ethnic Study of Atherosclerosis","volume":"35","author":"Guan","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.jlr.2024.100585_bib56","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1161\/CIRCULATIONAHA.111.045120","article-title":"Associations between lipoprotein(a) levels and cardiovascular outcomes in black and white subjects: the Atherosclerosis Risk in Communities (ARIC) Study","volume":"125","author":"Virani","year":"2012","journal-title":"Circulation"}],"container-title":["Journal of Lipid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227524000907?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227524000907?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T02:55:35Z","timestamp":1778640935000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022227524000907"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":56,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S0022227524000907"],"URL":"https:\/\/doi.org\/10.1016\/j.jlr.2024.100585","relation":{},"ISSN":["0022-2275"],"issn-type":[{"value":"0022-2275","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Associations between lipoprotein(a), oxidized phospholipids, and extracoronary vascular disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Lipid Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jlr.2024.100585","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"100585"}}